A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density

  1. Inicio
  2. »
  3. Sin categoría
  4. »
  5. A randomized, double-blind phase 2 clinical trial of blosozumab, a...
Patrocinadores de la web
Lilly
Laboratorios Rubió
Grupo Italfármaco
UCB-Pharma
Theramex
Stada
Gedeon Richter
Kyowa Kirin
Amgen
Gebro
Faes Farma
Meiji Pharma
Meiji Pharma